{"id":8,"date":"2016-08-10T08:51:14","date_gmt":"2016-08-10T08:51:14","guid":{"rendered":"https:\/\/www.malattiedelsangue.org\/fms\/?page_id=8"},"modified":"2024-03-05T11:34:11","modified_gmt":"2024-03-05T10:34:11","slug":"progetti","status":"publish","type":"page","link":"https:\/\/www.malattiedelsangue.org\/fms\/progetti\/","title":{"rendered":"PROGETTI"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-position:left top;--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-border-sizes-left:0px;--awb-border-sizes-right:0px;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:150px;--awb-padding-right:5.5%;--awb-padding-bottom:150px;--awb-padding-left:5.5%;--awb-background-image:linear-gradient(180deg, var(--awb-color1) 0%,var(--awb-color1) 100%);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-one\" style=\"--awb-text-color:#000000;--awb-margin-top-small:0px;--awb-margin-right-small:0px;--awb-margin-bottom-small:20px;--awb-margin-left-small:0px;\"><h1 class=\"fusion-title-heading title-heading-left\" style=\"font-family:&quot;Ubuntu&quot;;font-style:normal;font-weight:400;margin:0;\"><h3 style=\"text-align: center;\">I nostri progetti di ricerca<\/h3><\/h1><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container\"><div class=\"title-sep sep-single sep-solid\" style=\"border-color:#e0dede;\"><\/div><\/div><\/div><style type=\"text\/css\">.fusion-portfolio-wrapper#fusion-portfolio-1 .fusion-portfolio-content{ padding: 25px 25px 25px 25px; text-align: left; }<\/style><div class=\"fusion-recent-works fusion-portfolio-element fusion-portfolio fusion-portfolio-1 fusion-portfolio-grid fusion-portfolio-paging-load-more-button fusion-portfolio-four fusion-portfolio-boxed fusion-portfolio-text fusion-portfolio-equal-heights fusion-portfolio-rollover\" data-id=\"-rw-1\" data-columns=\"four\"><style type=\"text\/css\">.fusion-portfolio-1 .fusion-portfolio-wrapper .fusion-col-spacing{padding:10px;}<\/style><div class=\"fusion-portfolio-wrapper\" id=\"fusion-portfolio-1\" data-picturesize=\"fixed\" data-pages=\"0\" style=\"margin:-10px;\"><article id=\"portfolio-1-post-8156\" class=\"fusion-portfolio-post fusion-col-spacing post-8156\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcolino\/\" rel=\"author\">M B<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2025-03-12T13:55:23+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2024\/10\/cicogna-300x214.png\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/bonus-bebe\/\">\n\t\t\t\t\t\tBonus beb\u00e8\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/bonus-bebe\/\" aria-label=\"Bonus beb\u00e8\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/bonus-bebe\/\">Bonus beb\u00e8<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Nasce al fine di garantire una continuit\u00e0 retributiva, assimilabile all\u2019assegno di maternit\u00e0. E\u2019 rivolto a coloro, donne e uomini, che sono inquadrati con un contratto atipico per la Divisione di Ematologia dell\u2019ASST Grande Ospedale Metropolitano Niguarda. In caso di maternit\u00e0, \u00e8 previsto un gettone mensile (indicativamente attorno ai 500 euro) dopo la scadenza del contratto. Tale contributo sar\u00e0 erogato per un massimo di 12 mesi, si \u00e8 stimato di poter erogare fino ad un massimo complessivo di 20mila euro annui. In cambio le aderenti, svolgeranno attivit\u00e0 di telelavoro coerenti con il loro contratto, in sinergia e secondo le indicazioni della S.C. di Ematologia.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-7675\" class=\"fusion-portfolio-post fusion-col-spacing post-7675\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:44:57+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2023\/06\/WhatsApp-Image-2023-03-06-at-16.50.46-2-300x214.jpeg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/contact-center-professionisti-pronti-a-rispondere\/\">\n\t\t\t\t\t\tContact Center, professionisti pronti a rispondere\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/contact-center-professionisti-pronti-a-rispondere\/\" aria-label=\"Contact Center, professionisti pronti a rispondere\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/contact-center-professionisti-pronti-a-rispondere\/\">Contact Center, professionisti pronti a rispondere<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Accogliere adeguatamente i pazienti non \u00e8 solo una questione di spazi e servizi, significa anche comunicare con loro in modo empatico, chiaro ed esaustivo, garantendo un accesso alle informazioni semplice e immediato.\r\n\r\n<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-6922\" class=\"fusion-portfolio-post fusion-col-spacing post-6922\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:46:57+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/10\/Leucemia-Mieloide-Acuta-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lma-nuovi-target-molecolari\/\">\n\t\t\t\t\t\tIdentificazione nuovi target molecolari nella terapia della leucemia mieloide acuta\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lma-nuovi-target-molecolari\/\" aria-label=\"Identificazione nuovi target molecolari nella terapia della leucemia mieloide acuta\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lma-nuovi-target-molecolari\/\">Identificazione nuovi target molecolari nella terapia della leucemia mieloide acuta<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>L\u2019obiettivo principale di questo progetto \u00e8 quello di fornire conoscenze fondamentali sul ruolo della via molecolare di Wnt nella persistenza delle cellule staminali leucemiche della LMA, residenti nel midollo osseo leucemico. <\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-6906\" class=\"fusion-portfolio-post fusion-col-spacing post-6906\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:50:13+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/10\/gneicol-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/gene-arsd-nuovo-marcatore-prognostico-llc\/\">\n\t\t\t\t\t\tIl gene ARSD: possibile nuovo marcatore prognostico nella leucemia linfatica cronica\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/gene-arsd-nuovo-marcatore-prognostico-llc\/\" aria-label=\"Il gene ARSD: possibile nuovo marcatore prognostico nella leucemia linfatica cronica\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/gene-arsd-nuovo-marcatore-prognostico-llc\/\">Il gene ARSD: possibile nuovo marcatore prognostico nella leucemia linfatica cronica<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Il progetto \u00e8 uno studio traslazionale condotto su un\u2019ampia casistica di pazienti (170) per valutare i principali fattori prognostici indicativi della progressione della malattia.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-6713\" class=\"fusion-portfolio-post fusion-col-spacing post-6713\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:51:11+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/09\/philosofy-300x214.png\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lmc-philosophi\/\">\n\t\t\t\t\t\tStudi di trascrittomica nella leucemia mieloide cronica\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lmc-philosophi\/\" aria-label=\"Studi di trascrittomica nella leucemia mieloide cronica\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/lmc-philosophi\/\">Studi di trascrittomica nella leucemia mieloide cronica<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Studio traslazionale volto a identificare \u201cl\u2019impronta genetica\u201d dei pazienti con LMC alla diagnosi e dopo terapia con nilotinib, per determinare i pazienti che rispondono alla terapia e quelli che invece sono resistenti.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-6684\" class=\"fusion-portfolio-post fusion-col-spacing post-6684\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:52:56+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/09\/food-1-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/llc-alimentazione-digiuno\/\">\n\t\t\t\t\t\tLeucemia linfatica cronica e le diverse condizioni di alimentazione e digiuno\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/llc-alimentazione-digiuno\/\" aria-label=\"Leucemia linfatica cronica e le diverse condizioni di alimentazione e digiuno\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/llc-alimentazione-digiuno\/\">Leucemia linfatica cronica e le diverse condizioni di alimentazione e digiuno<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Studio comparativo dei profili di espressione genica di linfociti B di pazienti con leucemia linfatica cronica (LLC) in diverse condizioni di alimentazione e digiuno.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-90\" class=\"fusion-portfolio-post fusion-col-spacing post-90\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:53:44+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/04\/catetere1-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/eccellenza-assistenziale\/\">\n\t\t\t\t\t\tEccellenza assistenziale\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/eccellenza-assistenziale\/\" aria-label=\"Eccellenza assistenziale\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/eccellenza-assistenziale\/\">Eccellenza assistenziale<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Il progetto prevede l\u2019inserimento di un (o pi\u00f9)  Medico Specialista Ematologo che svolga attivit\u00e0 a tempo pieno presso il Day Hospital e gli ambulatori di Ematologia dell\u2019 ASST Grande Ospedale Metroplitano Niguarda.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-92\" class=\"fusion-portfolio-post fusion-col-spacing post-92\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:54:56+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2016\/08\/IMG_9687-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/malatoopersona\/\">\n\t\t\t\t\t\tMalato o persona?\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/malatoopersona\/\" aria-label=\"Malato o persona?\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/malatoopersona\/\">Malato o persona?<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Affrontare una grave patologia rappresenta una grande sfida sotto tutti i punti di vista. Una diagnosi di questo tipo \u00e8 certamente una situazione che cambia la vita del paziente e dei familiari, costituisce una sfida non solo verso la malattia, ma anche nei confronti di se stesso.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-185\" class=\"fusion-portfolio-post fusion-col-spacing post-185\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:55:50+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2016\/08\/terapieinnovcolore-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/terapie-innovative\/\">\n\t\t\t\t\t\tTerapie innovative\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/terapie-innovative\/\" aria-label=\"Terapie innovative\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/terapie-innovative\/\">Terapie innovative<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Il progetto prevede l\u2019inserimento di un Medico Specialista Ematologo che svolga attivit\u00e0 a tempo pieno presso il Day Hospital e gli ambulatori di Ematologia dell\u2019Ospedale Niguarda.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-183\" class=\"fusion-portfolio-post fusion-col-spacing post-183\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:56:50+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2021\/09\/P2145603-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/laboratorio_sperimentazioni_cliniche\/\">\n\t\t\t\t\t\tTrials clinici e laboratorio di ricerca\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/laboratorio_sperimentazioni_cliniche\/\" aria-label=\"Trials clinici e laboratorio di ricerca\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/laboratorio_sperimentazioni_cliniche\/\">Trials clinici e laboratorio di ricerca<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda oltre alla parte di ricerca biologica e genetica, collabora strettamente con la Clinical Trial Unit (CTU) ossia l\u2019unit\u00e0 responsabile dell\u2019organizzazione e monitoraggio di tutti i percorsi richiesti per lo svolgimento delle sperimentazioni cliniche presso la SC-Ematologia rispettando le Good Clinical Practice.<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-97\" class=\"fusion-portfolio-post fusion-col-spacing post-97\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:57:41+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2016\/08\/formazione_specialistica-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/formazione-specialistica\/\">\n\t\t\t\t\t\tFormazione specialistica\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/formazione-specialistica\/\" aria-label=\"Formazione specialistica\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/formazione-specialistica\/\">Formazione specialistica<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Sostegno alla Scuola di specialit\u00e0 in Ematologia per giovani medici presso la Struttura di Ematologia dell\u2019ospedale Niguarda<\/p><\/div><\/div><\/div><\/article><article id=\"portfolio-1-post-94\" class=\"fusion-portfolio-post fusion-col-spacing post-94\"><div class=\"fusion-portfolio-content-wrapper\" style=\"border:1px solid #ebeaea;border-bottom-width:3px;background-color:rgba(255,255,255,0);\"><span class=\"vcard rich-snippet-hidden\"><span class=\"fn\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/\" rel=\"author\">Roberto Molinari<\/a><\/span><\/span><span class=\"updated rich-snippet-hidden\">2024-03-05T14:58:29+01:00<\/span><div  class=\"fusion-image-wrapper fusion-image-size-fixed\" aria-haspopup=\"true\">\n\t\t\t\t<img decoding=\"async\" width=\"300\" height=\"214\" src=\"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2016\/08\/IMG_9127-300x214.jpg\" class=\"attachment-portfolio-three size-portfolio-three wp-post-image\" alt=\"\" \/><div class=\"fusion-rollover\">\n\t<div class=\"fusion-rollover-content\">\n\n\t\t\t\t\n\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"fusion-rollover-title\">\n\t\t\t\t\t<a class=\"fusion-rollover-title-link\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/\">\n\t\t\t\t\t\tMacroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM\t\t\t\t\t<\/a>\n\t\t\t\t<\/h4>\n\t\t\t\n\t\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t\t\t<a class=\"fusion-link-wrapper\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/\" aria-label=\"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM\"><\/a>\n\t<\/div>\n<\/div>\n<\/div>\n<div class=\"fusion-portfolio-content\" style=\"background-color:rgba(255,255,255,0);\"><h2 class=\"entry-title fusion-post-title\"><a href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/\">Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM<\/a><\/h2><div class=\"fusion-content-sep sep-single sep-solid\" style=\"border-color:var(--awb-color6);\"><\/div><div class=\"fusion-post-content\"><p>Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.<\/p><\/div><\/div><\/div><\/article><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 has-pattern-background has-mask-background fusion-parallax-none nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-border-sizes-left:0px;--awb-border-sizes-right:0px;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:20px;--awb-padding-right:20px;--awb-padding-bottom:20px;--awb-padding-left:20px;--awb-background-image:linear-gradient(180deg, var(--awb-color1) 0%,var(--awb-color1) 100%),url(https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2020\/02\/campopapaveri.jpg);;--awb-background-size:cover;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-padding-right:11%;--awb-padding-left:11%;--awb-bg-size:cover;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-text fusion-text-1\"><p style=\"text-align: center; font-size: 24px; color: #800; font-weight: 300;\">Aiutaci a perseguire l\u2019efficienza e il progresso nella cura delle malattie del sangue: migliorare le possibilit\u00e0 di guarigione e di qualit\u00e0 di vita dei pazienti \u00e8 realizzabile grazie a te.<\/p>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator\" style=\"margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:40px;width:100%;max-width:200px;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;--awb-sep-color:#c42b2e;border-color:#c42b2e;border-top-width:3px;\"><\/div><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-2\"><h2 style=\"text-align: center; color: #fff;\">INSIEME POSSIAMO ESSERE LA DIFFERENZA<\/h2>\n<\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 has-pattern-background has-mask-background hundred-percent-fullwidth non-hundred-percent-height-scrolling fusion-equal-height-columns\" style=\"--awb-background-position:left top;--awb-border-sizes-top:0px;--awb-border-sizes-bottom:0px;--awb-border-sizes-left:0px;--awb-border-sizes-right:0px;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:0px;--awb-padding-right:0px;--awb-padding-bottom:0px;--awb-padding-left:0px;--awb-background-image:linear-gradient(180deg, var(--awb-color1) 0%,var(--awb-color1) 100%);--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-first\" style=\"--awb-padding-top:3%;--awb-padding-right:3%;--awb-padding-bottom:3%;--awb-padding-left:3%;--awb-bg-color:#cccccc;--awb-bg-color-hover:#cccccc;--awb-bg-size:cover;--awb-margin-top:10px;--awb-margin-bottom:10px;width:33.333333333333%;width:calc(33.333333333333% - ( ( 15px + 15px ) * 0.33333333333333 ) );margin-right: 15px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-column-content-centered\"><div class=\"fusion-column-content\"><div class=\"fusion-fa-align-center\"><i class=\"fb-icon-element-1 fb-icon-element fontawesome-icon fa-university fas circle-no\" style=\"--awb-font-size:55px;\"><\/i><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-3\" style=\"--awb-text-color:var(--awb-color7);\"><h5 style=\"text-align: center;\">Banco BPM<br \/>\nIBAN: IT96T0503401726000000043254<br \/>\nintestato a Fondazione Malattie del Sangue ets<\/h5>\n<\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_3 1_3 fusion-one-third\" style=\"--awb-padding-top:3%;--awb-padding-right:3%;--awb-padding-bottom:3%;--awb-padding-left:3%;--awb-bg-color:#993333;--awb-bg-color-hover:#993333;--awb-bg-size:cover;--awb-margin-top:10px;--awb-margin-bottom:10px;width:33.333333333333%;width:calc(33.333333333333% - ( ( 15px + 15px ) * 0.33333333333333 ) );margin-right: 15px;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-column-content-centered\"><div class=\"fusion-column-content\"><div class=\"fusion-fa-align-center\"><i class=\"fb-icon-element-2 fb-icon-element fontawesome-icon fa-percentage fas circle-no\" style=\"--awb-font-size:55px;\"><\/i><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-4\" style=\"--awb-text-color:var(--awb-color1);\"><h5 style=\"text-align: center;\">5 X mille<br \/>\nCodice Fiscale: 97487060150<\/h5>\n<\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_3 1_3 fusion-one-third fusion-column-last\" style=\"--awb-padding-top:3%;--awb-padding-right:3%;--awb-padding-bottom:3%;--awb-padding-left:3%;--awb-bg-color:#cccccc;--awb-bg-color-hover:#cccccc;--awb-bg-size:cover;--awb-margin-top:10px;--awb-margin-bottom:10px;width:33.333333333333%;width:calc(33.333333333333% - ( ( 15px + 15px ) * 0.33333333333333 ) );\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-column-wrapper-legacy\"><div class=\"fusion-column-content-centered\"><div class=\"fusion-column-content\"><div class=\"fusion-fa-align-center\"><i class=\"fb-icon-element-3 fb-icon-element fontawesome-icon fa-mail-bulk fas circle-no\" style=\"--awb-font-size:55px;\"><\/i><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-sep-clear\"><\/div><div class=\"fusion-text fusion-text-5\" style=\"--awb-text-color:var(--awb-color7);\"><h5 style=\"text-align: center;\">bollettino postale:<br \/>\nc\/c postale n. 42497206<br \/>\nintestato a Fondazione Malattie del Sangue ets<\/h5>\n<\/div><\/div><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_price":"","_stock":"","_tribe_ticket_header":"","_tribe_default_ticket_provider":"","_tribe_ticket_capacity":"0","_ticket_start_date":"","_ticket_end_date":"","_tribe_ticket_show_description":"","_tribe_ticket_show_not_going":false,"_tribe_ticket_use_global_stock":"","_tribe_ticket_global_stock_level":"","_global_stock_mode":"","_global_stock_cap":"","_tribe_rsvp_for_event":"","_tribe_ticket_going_count":"","_tribe_ticket_not_going_count":"","_tribe_tickets_list":"[]","_tribe_ticket_has_attendee_info_fields":false,"footnotes":"","_tec_slr_enabled":"","_tec_slr_layout":""},"class_list":["post-8","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"it_IT\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Fondazione Malattie del Sangue E.T.S. - Insieme per l&#039;ematogia del Niguarda\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.\" \/>\n\t\t<meta property=\"og:description\" content=\"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2016-08-11T15:10:06+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-03-05T13:58:29+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/FondazioneMalattiedelSangue\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/progetti\\\/#listItem\",\"name\":\"PROGETTI\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/progetti\\\/#listItem\",\"position\":2,\"name\":\"PROGETTI\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#listItem\",\"name\":\"Home\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#organization\",\"name\":\"Fondazione Malattie del Sangue E.T.S\",\"description\":\"Insieme per l'ematogia del Niguarda\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/\",\"telephone\":\"+39026425491\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/FMSonlus_RAFFA_lungo.png\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#organizationLogo\",\"width\":3767,\"height\":1257},\"image\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/FondazioneMalattiedelSangue\",\"https:\\\/\\\/instagram.com\\\/FondazioneMalattiedelSangue\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/author\\\/marcobrusati\\\/#author\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/author\\\/marcobrusati\\\/\",\"name\":\"Roberto Molinari\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1b94233db8c9c1d24008f887b71a9e99e4cae3fc1e26835eccd557f7af9b679?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Roberto Molinari\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#webpage\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/\",\"name\":\"Macroglobulinemia di Waldenstr\\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.\",\"description\":\"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\\u2019Ematologia di Niguarda.\",\"inLanguage\":\"it-IT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/author\\\/marcobrusati\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/author\\\/marcobrusati\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/wp-content\\\/uploads\\\/2016\\\/08\\\/IMG_9127-scaled.jpg\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#mainImage\",\"width\":2560,\"height\":1400},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/portfolio-items\\\/studio-wm\\\/#mainImage\"},\"datePublished\":\"2016-08-11T15:10:06+01:00\",\"dateModified\":\"2024-03-05T14:58:29+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#website\",\"url\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/\",\"name\":\"Fondazione Malattie del Sangue ETS\",\"alternateName\":\"FMS ets\",\"description\":\"Insieme per l'ematogia del Niguarda\",\"inLanguage\":\"it-IT\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.malattiedelsangue.org\\\/fms\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.","description":"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.","canonical_url":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.malattiedelsangue.org\/fms\/#listItem","position":1,"name":"Home","item":"https:\/\/www.malattiedelsangue.org\/fms\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.malattiedelsangue.org\/fms\/progetti\/#listItem","name":"PROGETTI"}},{"@type":"ListItem","@id":"https:\/\/www.malattiedelsangue.org\/fms\/progetti\/#listItem","position":2,"name":"PROGETTI","previousItem":{"@type":"ListItem","@id":"https:\/\/www.malattiedelsangue.org\/fms\/#listItem","name":"Home"}}]},{"@type":"Organization","@id":"https:\/\/www.malattiedelsangue.org\/fms\/#organization","name":"Fondazione Malattie del Sangue E.T.S","description":"Insieme per l'ematogia del Niguarda","url":"https:\/\/www.malattiedelsangue.org\/fms\/","telephone":"+39026425491","logo":{"@type":"ImageObject","url":"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2023\/04\/FMSonlus_RAFFA_lungo.png","@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#organizationLogo","width":3767,"height":1257},"image":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#organizationLogo"},"sameAs":["https:\/\/facebook.com\/FondazioneMalattiedelSangue","https:\/\/instagram.com\/FondazioneMalattiedelSangue"]},{"@type":"Person","@id":"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/#author","url":"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/","name":"Roberto Molinari","image":{"@type":"ImageObject","@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/d1b94233db8c9c1d24008f887b71a9e99e4cae3fc1e26835eccd557f7af9b679?s=96&d=mm&r=g","width":96,"height":96,"caption":"Roberto Molinari"}},{"@type":"WebPage","@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#webpage","url":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/","name":"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.","description":"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.","inLanguage":"it-IT","isPartOf":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/#website"},"breadcrumb":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#breadcrumblist"},"author":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/#author"},"creator":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/author\/marcobrusati\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.malattiedelsangue.org\/fms\/wp-content\/uploads\/2016\/08\/IMG_9127-scaled.jpg","@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#mainImage","width":2560,"height":1400},"primaryImageOfPage":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/#mainImage"},"datePublished":"2016-08-11T15:10:06+01:00","dateModified":"2024-03-05T14:58:29+01:00"},{"@type":"WebSite","@id":"https:\/\/www.malattiedelsangue.org\/fms\/#website","url":"https:\/\/www.malattiedelsangue.org\/fms\/","name":"Fondazione Malattie del Sangue ETS","alternateName":"FMS ets","description":"Insieme per l'ematogia del Niguarda","inLanguage":"it-IT","publisher":{"@id":"https:\/\/www.malattiedelsangue.org\/fms\/#organization"}}]},"og:locale":"it_IT","og:site_name":"Fondazione Malattie del Sangue E.T.S. - Insieme per l'ematogia del Niguarda","og:type":"article","og:title":"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.","og:description":"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda.","og:url":"https:\/\/www.malattiedelsangue.org\/fms\/portfolio-items\/studio-wm\/","article:published_time":"2016-08-11T15:10:06+00:00","article:modified_time":"2024-03-05T13:58:29+00:00","article:publisher":"https:\/\/facebook.com\/FondazioneMalattiedelSangue","twitter:card":"summary_large_image","twitter:title":"Macroglobulinemia di Waldenstr\u00f6m: studio di alterazioni genetiche implicate nel rischio di progressione di IgM MGUS in WM - Fondazione Malattie del Sangue E.T.S.","twitter:description":"Il progetto intende fornire le risorse strumentali (reagenti, materiali di consumo e manutenzione della strumentazione di laboratorio) necessarie alla continuazione ed all\u2019evoluzione dello studio genetico e biologico della Macroglobulinemia di Waldenstrom (WM), iniziato nel 2010, presso il Laboratorio di Ricerca dell\u2019Ematologia di Niguarda."},"aioseo_meta_data":{"post_id":"8","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2023-06-09 11:05:58","updated":"2025-09-16 08:15:27","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.malattiedelsangue.org\/fms\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tPROGETTI\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.malattiedelsangue.org\/fms\/"},{"label":"PROGETTI","link":"https:\/\/www.malattiedelsangue.org\/fms\/progetti\/"}],"ticketed":false,"_links":{"self":[{"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/pages\/8","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/comments?post=8"}],"version-history":[{"count":0,"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/pages\/8\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.malattiedelsangue.org\/fms\/wp-json\/wp\/v2\/media?parent=8"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}